U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758140) titled 'Comparative Self-collection for Cervical Cancer Screening Pivotal Study' on Aug. 06.
Brief Summary: To evaluate whether individuals drawn from the intended use population can successfully interpret and follow the IFU for the Mia by XytoTest self-collection device and perform a vaginal sample collection yielding sufficient cellular material for primary hrHPV screening.
To assess the clinical performance of Mia self-collected vaginal specimens by evaluating agreement with paired clinician-collected cervical specimens for the detection of high-risk HPV, when both specimen types are analyzed using the cobas HPV Test (Roche Molecular Sy...